HCD Unveils Social Monitoring Service

In the US, marketing and comms specialist HCD Research has launched a new syndicated social monitoring service to help pharmaceutical marketers qualitatively understand consumers' and physicians' sentiment associated with their brands.

Headquartered in Flemington, NJ, HCD Research offers traditional and web-based marketing and communications research.

Its new NetClassRX solution enables marketers to sift through digital conversations about their brands and competitor brands by using proprietary algorithms to extract data from web sites, forums, blogs and social networks.

It also contains a dashboard to allow marketers to view consumer sentiment on a daily basis and physician sentiment monthly or quarterly.

The service enables marketers to view an analysis of aggregate data which quantifies the ratio of positive to negative comments for each product in a class of drugs.

In addition, the service categorizes positive and negative comments so that marketers can determine how consumers view a brand and a class of drugs on important product attributes.

'The service allows brand managers to view their brands' health on-line and compare it to the health of competitor brands,' explains CEO Glenn Kessler. 'It also allows them to detect rumors and determine the impact of new product claims and other news related to their brand within 24 hours.'

Web site: www.hcdi.net .